ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

November 3, 2006

AACI To Seek Line Item For Centers In Cancer Act Renewal

January 18, 1980

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995